LMS to streamline operations

    MONTREAL, Oct. 24 /CNW Telbec/ - LMS Medical Systems (TSX: LMZ, AMEX:  
LMZ), a healthcare technology company and developer of the CALM-clinical
information system and risk management software tools for obstetrics, today
announced that it is streamlining operations, thereby substantially reducing
the company's expenses with the objective of reaching near term positive cash
flow and ensuing profitability. LMS recently launched its flagship software
applications and will now focus on growing market presence and product
    The September 2007 announcement of the successful integration of its CALM
product with a distributor's clinical platform and the market delivery of
additional strategic products allows for the reorientation of the company's
operations. Sales, service, training and software support for the Company's
distributors and healthcare industry clients become the priority. Shifting
from software development to commercialization allows for reductions in
development expenses and outside consultants.
    "Management will concentrate its efforts primarily on ramping up revenue
generation, servicing our growing customer base and profitability." said Diane
Côté, President and CEO of LMS. "We will continue to look at developing
additional partnerships to increase market presence."


    LMS is a leader in the application of advanced mathematical modeling and
neural networks for medical use. The LMS CALM(TM) Suite provides physicians,
nursing staff, risk managers and hospital administrators with clinical
information systems and risk management tools designed to improve outcomes and
patient care for mothers and their infants during childbirth.

    Except for historical information contained herein, the matters discussed
in this news release are forward-looking statements. Because these
forward-looking statements involve risks and uncertainties, there are
important factors that could cause actual results to differ materially from
those expressed implied by the forward-looking statements including, but
without limitation, economic conditions in general and in the healthcare
market, the demand for and market for our products in domestic and
international markets, our current dependence on the CALM product suite, the
challenges associated with developing new products and obtaining regulatory
approvals if necessary, research and development activities, the uncertainty
of acceptance of our products by the medical community, the lengthy sales
cycle for our products, third party reimbursement, competition in our markets,
including the potential introduction of competitive products by others, our
dependence on our distributors, physician training, enforceability and the
costs of enforcement of our patents, potential infringements of our patents
and the other factors set forth from time to time in the Company's filings
with the United States Securities and Exchange Commission and with the
Canadian Securities Commissions. The Company has no intention of or obligation
to update or revise any forward-looking statements, whether as a result of new
information, future events or otherwise.

For further information:

For further information: Yves Grou, Chief Financial Officer, LMS Medical
Systems Inc., (514) 488-3461 Ext. 238, Fax: (514) 488-1880,
yves@lmsmedical.com, www.lmsmedical.com

Organization Profile


More on this organization

Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

CNW Membership

Fill out a CNW membership form or contact us at 1 (877) 269-7890

Learn about CNW services

Request more information about CNW products and services or call us at 1 (877) 269-7890